Search results
Results from the WOW.Com Content Network
Hyperventilation is irregular breathing that occurs when the rate or tidal volume of breathing eliminates more carbon dioxide than the body can produce. [ 1 ] [ 2 ] [ 3 ] This leads to hypocapnia , a reduced concentration of carbon dioxide dissolved in the blood.
Hyperventilation syndrome (HVS), also known as chronic hyperventilation syndrome (CHVS), dysfunctional breathing hyperventilation syndrome, cryptotetany, [1] [2] spasmophilia, [3] [4] [5] latent tetany, [4] [5] and central neuronal hyper excitability syndrome (NHS), [3] is a respiratory disorder, psychologically or physiologically based, involving breathing too deeply or too rapidly ...
This explains the other common symptoms of hyperventilation—pins and needles, muscle cramps and tetany in the extremities, especially hands and feet. [ citation needed ] Because the brain stem regulates breathing by monitoring the level of blood CO 2 instead of O 2 , hypocapnia can suppress breathing to the point of blackout from cerebral ...
Treatment-emergent central sleep apnea (TECSA), also known as complex sleep apnea, is a type of sleep apnea that typically develops when a patient starts CPAP therapy for OSA. This can occur when ...
Central neurogenic hyperventilation (CNH) is an abnormal pattern of breathing characterized by deep and rapid breaths at a rate of at least 25 breaths per minute. Increasing irregularity of this respiratory rate generally is a sign that the patient will enter into coma .
The Buteyko method emphasizes the role of carbon dioxide and hyperventilation in respiratory diseases as well as overall health. It is known that hyperventilation can lead to low carbon dioxide levels in the blood (or hypocapnea), which can subsequently lead to disturbances of the acid-base balance in the blood and lower tissue oxygen levels.
Ketamine’s antidepressant effects are part of what prompted researchers to explore other drugs that target glutamate—like the venerable cough suppressant dextromethorphan found in Robitussin ...
The toxic effects of salicylates have been described since at least 1877. [5] In 2004, more than 20,000 cases with 43 deaths were reported in the United States. [1] About 1% of those with an acute overdose die, while chronic overdoses may have severe outcomes. [3] Older people are at higher risks of toxicity for any given dose. [5]